OpenEvidence announced on November 11, 2026 that it had launched Access Intelligence, a suite built directly into its clinical AI platform and available immediately at no charge to all clinicians. The tools help with affordability and coverage tasks, including availability and eligibility information for more than 2,500 patient-support programs. Access Intelligence is designed for the work that comes after a treatment decision: determining whether a patient can afford and obtain the recommended…